314
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Clinical Knowledge, Attitude, and Perceptions of Community Pharmacists Towards Pharmacogenomics - A Cross-Sectional Study from Saudi Arabia

ORCID Icon, ORCID Icon, & ORCID Icon
Pages 433-441 | Received 05 Jan 2023, Accepted 24 Apr 2023, Published online: 08 May 2023

References

  • Arafah A, Rehman MU, Syed W, Babelghaith SD, Alwhaibi A, Al Arifi MN. Knowledge, attitude, and perception of pharmacy students towards pharmacogenomics and genetics: an observational study from King Saud University. Genes. 2022;13(2):269. doi:10.3390/genes13020269
  • Hundertmark ME, Waring SC, Stenehjem DD, et al. Pharmacist’s attitudes and knowledge of pharmacogenomics and the factors that may predict future engagement. Pharm Pract. 2020;18:2008.
  • Tuteja S, Haynes K, Zayac C, Sprague JE, Bernhardt B, Pyeritz R. Community pharmacists ‘attitudes towards clinical utility and ethical implications of pharmacogenetic testing. Per Med. 2013;10(8):793–800. doi:10.2217/pme.13.85
  • Koutsilieri S, Tzioufa F, Sismanoglou DC, Patrinos GP. Unveiling the guidance heterogeneity for genome-informed drug treatment interventions among regulatory bodies and research consortia. Pharmacol Res. 2020;153:104590. doi:10.1016/j.phrs.2019.104590
  • Leong SL, Chaiyakunapruk N, Tassaneeyakul W, Arunmanakul P, Nathisuwan S, Lee SWH. Roles of pharmacogenomics in non-anthracycline antineoplastic-induced cardiovascular toxicities: a systematic review and meta-analysis of genotypes effect. Int J Cardiol. 2019;280:190–197. doi:10.1016/j.ijcard.2018.12.049
  • Cavallari LH, Shin J, Perera MA. Role of pharmacogenomics in the management of traditional and novel oral anticoagulants. Pharmacotherapy. 2011;31:1192–1207. doi:10.1592/phco.31.12.1192
  • Yau A, Aziz ABA, Haque M. Knowledge, attitude and practice concerning pharmacogenomics among pharmacists: a systematic review. J Young Pharm. 2015;7:145–154. doi:10.5530/jyp.2015.3.3
  • Weitzel KW, Aquilante CL, Johnson S, Kisor DF, Empey PE. Educational strategies to enable expansion of pharmacogenomics-based care. Am J Health Syst Pharm. 2016;73:1986–1998. doi:10.2146/ajhp160104
  • NHS. Pharmacogenetics or pharmacogenomics: what’s the difference. Available from https://www.nw-gmsa.nhs.uk/news-and-events/latest-news-blogs/pharmacogenetics-or-pharmacogenomics-whats-difference. Accessed March 2, 2023.
  • Algahtani M. Knowledge, perception, and application of pharmacogenomics among hospital pharmacists in Saudi Arabia. Risk Manag Healthc Policy. 2020;13:1279. doi:10.2147/RMHP.S267492
  • El-Ibiary SY, Cheng C, Alldredge B. Potential roles for pharmacists in pharmacogenetics. J Am Pharm Assoc. 2008;48(2):e21–e32. doi:10.1331/JAPhA.2008.07050
  • McMahon T, Tucci J. The perceptions of pharmacists in Victoria, Australia on pharmacogenetics and its implications. Pharm Pract. 2011;9(3):141–147.
  • Muzoriana N, Gavi S, Nembaware V, Dhoro M, Matimba A. Knowledge, attitude, and perceptions of pharmacists and pharmacy students towards pharmacogenomics in Zimbabwe. Pharmacy. 2017;5(4):36. doi:10.3390/pharmacy5030036
  • Da P, Sl N, Bp S, Knowledge TSK. Awareness and attitude of pharmacists toward pharmacogenetic practice: perspective of community and hospital in Yogyakarta, Indonesia. J Community Med Health Educ. 2017;07(06):1–10. doi:10.4172/2161-0711.1000568
  • Elewa H, Alkhiyami D, Alsahan D, Abdel-Aziz A. A survey on the awareness and attitude of pharmacists and doctors towards the application of pharmacogenomics and its challenges in Qatar. J Eval Clin Pract. 2015;21(4):703–709. doi:10.1111/jep.12372
  • Syed W, Al-Rawi BA. Evaluation of knowledge of risk factors and warning signs of stroke-an observational study among future health care professionals. Front Public Health. 2023;11:474.
  • Alhazmi RA, Alobaid AM, Althunayyan SM, Syed W, Al-Rawi MB. A cross-sectional assessment of knowledge, awareness of risk factors, and perceptions of thyroid disease (TD) among adults living in Saudi Arabia–A community based study. Front Public Health. 2022;10. doi:10.3389/fpubh.2022.1041745
  • Kudzi W, Addy BS, Dzudzor B. Knowledge of pharmacogenetics among healthcare professionals and faculty members of health training institutions in Ghana. Ghana Med J. 2015;49:50–56. doi:10.4314/gmj.v49i1.9
  • Bannur Z, Bahaman S, Salleh MZ, Kek TL. Pharmacogenomics based practice in Malaysia: the attitude, knowledge and adoption by the healthcare professionals. Int Med J Malays. 2014;13:10.
  • Alexander KM, Divine HS, Hanna CR, Gokun Y, Freeman PR. Implementation of personalized medicine services in community pharmacies: perceptions of independent community pharmacists. J Am Pharm Assoc. 2014;54(5):510–7, 5 p following 517. PMID: 25148656; PMCID: PMC9226962. doi:10.1331/JAPhA.2014.13041
  • Petit C, Croisetière A, Chen F, Laverdière I. Are pharmacists from the province of Quebec ready to integrate pharmacogenetics into their practice. Pharmacogenomics. 2020;21(4):247–256. PMID: 32180495. doi:10.2217/pgs-2019-0144
  • Crown N, Sproule BA, Luke MJ, Piquette-Miller M, McCarthy LM. A continuing professional development program for pharmacists implementing pharmacogenomics into practice. Pharmacy. 2020;8(2):55. PMID: 32231164; PMCID: PMC7356265. doi:10.3390/pharmacy8020055
  • Youssef E, Wright D. Pharmacogenomic testing and its future in community pharmacy. Pharm J. 2020;304(7933):52–57.
  • Papastergiou J, Tolios P, Li W, Li J. The Innovative Canadian Pharmacogenomic Screening Initiative in Community Pharmacy (ICANPIC) study. J Am Pharm Assoc. 2017;57(5):624–629. PMID: 28689706. doi:10.1016/j.japh.2017.05.006
  • Rendell T, Barnett J, Wright D. How community pharmacy pharmacogenomics testing services around the world can inform their design and delivery in the UK. Pharm J. 2021;307(7955):7955.
  • Alejielat R, Ejielat Z, Andrawes S, Mhaidat NM. An evaluation of the knowledge, opinions, expectations and concerns toward pharmacogenomics among Jordanian pharmacists. Per Med. 2016;13(2):143–154. doi:10.2217/pme.15.50